These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15162420

  • 1. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
    LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W.
    Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
    [Abstract] [Full Text] [Related]

  • 2. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA, Leibundgut-Landmann S, Huarte J, Kos-Braun IC, Lavanchy C, Barras E, Borisch B, Steimle V, Acha-Orbea H, Reith W.
    Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 4. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW.
    Eur J Immunol; 2004 Feb 15; 34(2):471-80. PubMed ID: 14768052
    [Abstract] [Full Text] [Related]

  • 5. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
    Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B.
    EMBO J; 1997 May 15; 16(10):2851-60. PubMed ID: 9184229
    [Abstract] [Full Text] [Related]

  • 6. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 7. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
    LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W.
    Nat Immunol; 2004 Sep 15; 5(9):899-908. PubMed ID: 15322541
    [Abstract] [Full Text] [Related]

  • 8. Regulation of MHC class II gene expression by the class II transactivator.
    Reith W, LeibundGut-Landmann S, Waldburger JM.
    Nat Rev Immunol; 2005 Oct 15; 5(10):793-806. PubMed ID: 16200082
    [Abstract] [Full Text] [Related]

  • 9. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ.
    Mol Immunol; 2007 Mar 15; 44(8):2036-46. PubMed ID: 17067677
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic regulation of MHC-II and CIITA genes.
    Wright KL, Ting JP.
    Trends Immunol; 2006 Sep 15; 27(9):405-12. PubMed ID: 16870508
    [Abstract] [Full Text] [Related]

  • 11. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 12. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 13. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar 01; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 14. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 01; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic silencing of MHC2TA transcription in cancer.
    Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1570-6. PubMed ID: 16879803
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 30; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 17. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Eur J Immunol; 2007 Mar 30; 37(3):788-97. PubMed ID: 17304627
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A.
    Int J Biochem Cell Biol; 2006 Mar 30; 38(4):544-62. PubMed ID: 16343978
    [Abstract] [Full Text] [Related]

  • 19. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE, Yu HN, Yoon CH, Bae YS.
    Eur J Immunol; 2009 Mar 30; 39(3):858-68. PubMed ID: 19224634
    [Abstract] [Full Text] [Related]

  • 20. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, Ostrand-Rosenberg S.
    Cancer Res; 2006 Jan 15; 66(2):1147-54. PubMed ID: 16424052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.